Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden flag Sweden · Delayed Price · Currency is SEK
13.00
-1.15 (-8.13%)
Nov 2, 2026, 5:29 PM CET

Xbrane Biopharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-62.68127.24-266.22-388.17-172.51-188.38
Depreciation & Amortization
9.989.9824.2121.4316.5812.22
Other Operating Activities
11.34-311.55190.93145.36-7.25-5.04
Change in Accounts Receivable
3.8970.03-4.56-85.131.7-61.09
Change in Inventory
50.2548.98-166-56.6-50.26-
Change in Accounts Payable
280.03--22.57--
Change in Other Net Operating Assets
-368.78-368.78212.82-17.8322.67
Operating Cash Flow
-76.8-250.69-133.73-406.68-193.92-219.61
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
144.3--0.5-6.79-11.62-27.68
Sale (Purchase) of Intangibles
-281.19-139.64-51.75-9.98-48.51-49.67
Other Investing Activities
102.5102.5----
Investing Cash Flow
-34.38-37.14-52.25-16.77-60.13-77.35

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-77.670225--
Long-Term Debt Repaid
--47.78-126.14-34.74-8.34-7.27
Lease Payments
-0.95-4.28-13.64-13.91-8.34-7.27
Total Debt Repaid
-0.95-47.78-126.14-34.74-8.34-7.27
Net Debt Issued (Repaid)
56.6529.82-56.14190.26-8.34-7.27
Issuance of Common Stock
-240337.24120.02170.55380.87
Other Financing Activities
-0.17-14.22-37.48-11.58-13.35-24.23
Financing Cash Flow
56.47255.61243.62298.7148.86349.37

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.67-6.050.84-4.494.051.39
Miscellaneous Cash Flow Adjustments
0.220.530.440.64-0.05-1.76
Net Cash Flow
-56.15-37.7458.93-128.59-101.1952.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
67.5-250.69-134.23-413.47-205.53-247.29
Free Cash Flow Growth
------
Free Cash Flow Margin
52.76%-164.55%-90.64%-173.20%-356.72%-2309.16%
Free Cash Flow Per Share
3.28-15.25-13.64-1800.48-1004.76-1310.16
Levered Free Cash Flow
-190.12-347.0110.32-244-169.78-279.72
Unlevered Free Cash Flow
-187.21-339.4929.46-232.43-168.17-278.07
Free Cash Flow After Leases
66.55-254.97-147.87-427.38-213.87-254.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.485.4817.657.582.592.64
Change in Working Capital
-34.6-249.7742.27-119.16-30.73-38.42